AKT1 and colorectal cancer: rhREG4 treatment promoted G2 progression for the mitogenesis of colorectal cancer cells by Akt/glycogen synthase kinase three β (GSK3β)/β-catenin/transcription factor 4 (TCF-4) signaling (Bishnupuri et al., 2014).